ILIXABEP
Dead / Abandoned — Abandoned — after publication (as of 29 Sept 2008)
What this means for you
This application is over — abandoned 28 Sept 2008. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78397956
- Mark type
- Stylized text
- Filed
- 07 Apr 2004
- Published for opposition
- 12 Jul 2005
- Abandoned
- 28 Sept 2008
- Attorney of record
- Nadine P. Flynn
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations used to increase heart rate and contrast imaging agents
Owner
- Bristol-Myers Squibb Company, New York, NY, US
- Bristol-Myers Squibb Company, New York, NY, US
Prosecution history
- 29 Sept 2008 — ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
- 29 Sept 2008 — ABANDONMENT - AFTER PUBLICATION
- 28 Sept 2008 — TEAS EXPRESS ABANDONMENT RECEIVED
- 21 Mar 2008 — SOU EXTENSION 5 GRANTED
- 21 Mar 2008 — SOU EXTENSION 5 FILED
- 21 Mar 2008 — SOU TEAS EXTENSION RECEIVED
- 19 Sept 2007 — SOU EXTENSION 4 GRANTED
- 19 Sept 2007 — SOU EXTENSION 4 FILED
- 19 Sept 2007 — SOU TEAS EXTENSION RECEIVED
- 30 Mar 2007 — SOU EXTENSION 3 GRANTED
- 30 Mar 2007 — SOU EXTENSION 3 FILED
- 30 Mar 2007 — SOU TEAS EXTENSION RECEIVED
- 21 Aug 2006 — SOU EXTENSION 2 GRANTED
- 21 Aug 2006 — SOU EXTENSION 2 FILED
- 21 Aug 2006 — SOU TEAS EXTENSION RECEIVED